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Objectives: Incidental findings (IF) are becoming increasingly common due to the
proliferation of imaging research. IFs can be life-changing for ‘‘healthy’’ volunteers.
This study examined variation in IF management in UK research studies of healthy
volunteers, including comparison with ethical and legal guidelines, thus providing
baseline data and informing future practice.
Methods: Questionnaire of participant background [medical/non-medical;
radiologist/non-radiologist; years as principal investigator (PI)], type of research
(involving children or not), institutional policy, volunteer information, radiologist
involvement in reporting scans and IF disclosure mechanisms. Investigator’s current
and perceived ‘‘ideal’’ practice was examined. Participants were PIs performing
imaging research of healthy volunteers approved by UK ethics committees
(2006–2009).
Results: 63/146 (43%) surveys completed. 54/61 (88.5%) had site-specific guidelines.
Information commonly provided to volunteers should IF be found: personal data
(51/62; 82%), contingency plans (54/62; 87%) and disclosure to general practitioner
(GP)/treating physician (47/62; 76%). PIs used different strategies for image review.
Commonest: radiologist reports research scans only when researcher suspicious of IF
[15/57 (26%) compared with 5/28 (16%) in ideal practice]. Commonest ideal reporting
strategy: routine reporting by specialist radiologists [9/28 (29%) compared with 8/57
(14%) in current practice]. 49/56 (87.5%) have a standardised disclosure contingency
plan, usually involving GP. PIs most commonly disclosed IFs to volunteers when judged
relevant (27/58; 47%), most commonly face to face (22/54; 41%), by volunteer’s GP (26/
60; 43%). Background of PI influenced consent, reporting and disclosure practice.
Conclusion: There is wide variation in handling IFs in UK imaging research. Much of
the current practice contravenes the vague existing legal and ethical guidelines, and is
unlikely to be in the best interests of volunteers or researchers.
Received 16 November
2010
Revised 15 January 2011
Accepted 7 February 2011
DOI: 10.1259/bjr/73283917
’ 2012 The British Institute of
Radiology
The term ‘‘incidental finding’’ may give the impres-
sion that an unexpected finding is trivial, but an incidental
finding (IF) can be life-changing [1]. One definition is ‘‘a
finding that has potential health or reproductive impor-
tance which is discovered in the course of conducting
research, but is beyond the aims of the study’’ [2]. The
wider use of imaging in research is making incidental
imaging findingsmore common, and recent academic and
popular press editorials have highlighted the need for
better management [3, 4]. Advancing research practice
is controversial and has led to recent debate [5] and
deadlock [6] among imaging researchers in Europe and
North America.
IFs are common in research imaging. Their prevalence
on brain MRI was 2.7% across 16 studies involving 19 559
participants [7] and may be as high as 12.8% on body
MRI [8]. Extracolonic IFs at CT colonography require
further investigation, medical or surgical intervention in
5–8% [9]. There are, therefore, important implications for
informed consent, clinical review of images and mechan-
isms for notifying the subject. For the volunteers them-
selves, an IF may have serious implications for health,
employment, medical or life insurance, and their state
of mind. Furthermore, irrelevant imaging features in-
correctly identified as pathological by non-radiologically
trained researchers may cause unnecessary distress.
We recently reviewed UK, European and other
international legal and ethical guidance on management
of IFs, and limited available information on volunteers’
expectations. Current recommendations are consistent
with the principles that research volunteers should be
informed of how their research images will be managed,
that there should be measures for identifying and act-
ing on IFs, and information should be disclosed to the
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subject and his or her responsible physician in a timely,
sensitive and appropriate manner [10]. However, this
guidance is hard to find and ambiguous, and does not
distinguish management of imaging from other types of
research sample. We suspected that management of IFs
varies considerably between imaging research centres,
but lacked reliable data on current practice. We have
therefore surveyed UK imaging researchers to determine
how IFs are currently managed to provide baseline data
to inform future UK practice.
Methods
Participants
The UK National Research Ethics Service (NRES)
provided written confirmation that ethical approval was
not necessary for this questionnaire-based study (Ref: 04/
12). Eligible participants were lead or principle investiga-
tors (PIs) of at least one imaging research study using
‘‘healthy’’ volunteers between 2006 and 2009 that had
been approved by a UK ethics committee. No national data-
base of imaging researchers exists; we therefore identified
potential participants’ contact details through research
institution websites, and by liaison with relevant man-
agers, heads of departments and known researchers.
Survey design
We produced hard-copy and automated internet ver-
sions of the questionnaire (SurveyMonkey.com, Portland,
OR). We used tailored design and bimodal methodology
for internet surveys to optimise quality and participant
response [11–14]. All responses were anonymous. The
definition of an IF was highlighted at the start of the
questionnaire [2]. PIs were asked to answer the ques-
tionnaire in relation to their latest imaging study and to
confirm that they had ethics approval for that study. We
sought information on participant background (medical/
non-medical; radiologist/non-radiologist; number of years
as PI), type of research (involving children or not), any
policy on IFs at their site, information given to volunteers,
involvement of radiologists in reporting of scans and
mechanisms for disclosure of any IFs (Appendix A). We
defined medical as possessing a medical degree (Bachelor
of Medicine and Surgery, or equivalent) and currently
practising medicine. We sought information both on
current practice and on what PIs considered to be ideal
practice (defined as ‘‘practice without funding or time
constraints’’).
Statistical analysis
We compiled data from the completed questionnaires
in Microsoft Excel (Microsoft Corp., Seattle, WA) and
tested for normality (http://home.ubalt.edu/ntsbarsh/
Business-stat/otherapplets/Descriptive.htm). We used
the two-tailed Yates corrected x2 test (or for small numbers
Fisher’s exact test) for comparisons between groups
(http://statpages.org/ctab2x2.html), except for non-
parametric continuous and ordered categorical data (e.g.
size of institution, years as PI, trends in reporting), in
which cases we used the two-tailedMann–WhitneyU-test
(http://elegans.swmed.edu/,leon/stats/utest.cgi).
Statistical significance was set at p,0.05. The null hypo-
thesis was that there would be no difference between PIs
in current UK practice in the management of IFs; we also
explored differences in ideal practice.
Results
Subject characteristics
We identified 160 potential participants, although 3
(2%) could not be contacted and 14 (9%) said that they
were ineligible. Of the 146 eligible participants, 63 (43%;
on an ‘‘intention to survey’’ basis) completed the ques-
tionnaire (Table 1). Non-medical PIs were more likely
than medical PIs to image the brain (Yates corrected x2
test p,0.0001) and use functional MRI (p,0.0001), but
were no more likely to image children (Fisher’s exact
test p50.74). Years as PI (Mann–Whitney U-test p50.75)
or size of institution (p50.54) did not differ between
medical and non-medical PIs.
Site-specific guidelines
61 respondents answered this question, of whom 54
(88.5%) had site-specific guidelines, 47 (77%) giving a
brief description. Here, most PIs explained that research
ethics committee approval was required. Type of PI
(medical and non-medical, p50.69; radiologist and non-
radiologist, p50.38), subject (children or adults, p50.31),
years as PI (p50.14) and size of institution (p50.88)
were not associated with whether an institution had
guidelines.
Consent
Most PIs currently provide information to volunteers
on handling of personal data (51/62; 82%), contingency
plans (54/62; 87%) and disclosure to a general practi-
tioner (GP)/treating physician (47/62; 76%) should an IF
be found (Questions 1–3 in Table 2). Most PIs do not
currently provide other information listed in Table 2
(Questions 4–9), and even fewer PIs thought it ideal to
provide volunteers with this information.
Medical PIs were more likely than non-medical PIs to
indicate that IFs would be disclosed to the volunteer by a
member of the research team (p,0.0001), to indicate
whether any IFs were likely to be treatable (p50.047) and
to indicate whether there would be potential future re-
contact if the data were to be re-analysed (p50.017).
Radiologists were more likely than non-radiologists to
discuss potential benefits of identifying any incidental
lesion (p50.048). The number of years as PI and type of
research subjects was not associated with this aspect of
practice.
The only difference in ideal practice was that medical
PIs were more likely than non-medical PIs to opt for
discussion with volunteers regarding the investigator’s
T C Booth, A D Waldman, J M Wardlaw et al
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Table 1. Background respondent characteristics. This table demonstrates the background characteristics of the 63 (43%)
principal investigators (PIs) responding to this survey
Characteristic Value n (%) Characteristic Value n (%)
Most frequent respondents’ locations
(total n561)
Most common PI disciplinesc (total n562)
London 16 (26) Psychologist 14 (23)
Oxford 11 (18) Radiologist (not neuroradiologist) 10 (16)
Manchester 5 (8) Basic scientist 9 (15)
Neuroradiologist 8 (13)
Size of institution based on total
number of studentsa (total n556)
Physicist 7 (11)
,10000 15 (24)
10000–19999 24 (39)
20000–29999
30000–39999
8 (13)
3 (5)
Most common research modality and methodc,d (total n561)
MRI structural sequences 45 (74)
.40000 6 (10) fMRI 31 (51)
PI type (total n562)
MRI whole volume brain sequences 25 (41)
Medicalb
Non-medical
35 (57)
27 (44)
MRI diffusion tensor imaging
MR spectroscopy
21 (34)
18 (31)
MRI perfusion imaging 15 (25)
MRI diffusion imaging 14 (23)
Time as PI (total n562) MRI permeability imaging 7 (12)
Years (median; range) 10; 1–39
Research subject typec (total n562)
Adult 62 (98)
Child 10 (16)
Most common research organ(s)
imagedc (total n562)
Brain 47 (76)
Cardiac 7 (11)
Gastrointestinal tract 5 (8)
a6 PIs marked ‘‘not applicable’’.
bBachelor of medicine and surgery (or equivalent) and currently practicing medicine.
cRespondents could indicate more than one field.
dStructural sequences include T1, T2, fluid-attenuated inversion-recovery and T2*.
Table 2. Information given to the volunteer during the process of obtaining consent. This table demonstrates the principal
investigator (PI) responses to the question: ‘‘during the process of obtaining informed consent from the volunteer by the
researcher, information is provided on which of the following?’’
Answer option(s) Number of PIs answering ‘Yes’a (total of n562)
Current practice n (%) Ideal practice n (%)
1. What happens to the patient’s personal data 51 (82) 26 (42)
2. Contingency plans should any incidental findings be foundb 54 (87) 21 (34)
3. Disclosure of any incidental findings to the volunteer’s
general practitioner/treating clinician
47 (76) 16 (26)
4. Disclosure of any incidental findings to the volunteer
themselves by a member of the research team
24 (39) 16 (26)
5. Whether any incidental findings are likely to be treatable 13 (21) 11 (18)
6. Potential benefits of any incidental findings should they be
found (e.g. prophylactic intervention)
16 (26) 13 (21)
7. Potential harms of any incidental findings should they be
found (e.g. medical insurance being affected)
19 (31) 19 (31)
8. The extent (if any) of the investigator’s responsibility to provide
medical services should any incidental finding be found
26 (42) 19 (31)
9. Potential future re-contact in anticipation that the data be
re-analysed in the future after this project has finished
23 (37) 20 (32)
aPIs were informed that they could choose more than one option.
bExamples are: (a) a suitable mechanism is always in place for disclosure of an incidental finding to the volunteer; (b) the plan is
to always not disclose.
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responsibility to provide medical services should any IF
be found (p50.036).
Radiology reporting
57 (90%) and 28 (44%) of 63 respondents answered the
question on radiologist involvement in research imaging
in current and ideal practice, respectively (Figure 1).
Strategies for image review varied; the most common
current policy (15/57; 26%) was to request radiologists
to report research scans only when a researcher was
suspicious of an IF, although only 5/28 (16%) considered
this ideal practice. The commonest ideal reporting
strategy was for routine reporting by specialist radiolo-
gists 9/28 (29%), but this was current practice for only
8/57 (14%) PIs.
Medically trained PIs were more likely than non-
medical PIs to take a proactive approach (i.e. radiologist
reporting of all scans, obtaining additional scans routi-
nely, specialist reporting or combinations thereof) to
identify IFs (p50.041). The tendency towards proactive
image review and specialist reporting was even more
marked when radiologist PIs were compared with non-
radiologists (p50.007). However, no other PI or subject
characteristics were associated with research scan report-
ing strategy or trend in current or ideal practice.
Disclosure of findings
Of the 56 respondents who answered whether their
institution had a standardised contingency plan for
disclosure of IFs, 49 (87.5%) confirmed such an arrange-
ment. 35 (62.5%) gave a brief description; in most cases the
GP would be informed of any IF. All (26/26) respondents
felt that standardised contingency planswere ideal practice.
We received a variety of responses to when, how and
by whom IFs were disclosed to volunteers (Table 3). PIs
most commonly disclosed IFs to volunteers when judged
relevant (27/58, 47%), and a similar percentage thought
this ideal (12/26, 46%). Face-to-face disclosure was the
most common method of communication (22/54, 41%),
and was thought by many to be ideal (19/27, 70%).
Disclosure was most commonly by the volunteer’s GP
(26/60, 43%), which was also thought ideal practice
(9/28, 32%).
Non-medical PIs were significantly more likely never
to disclose IFs to the volunteer (p50.003). The two
common reasons given were that non-clinicians process
the images (6/12), and that disclosure was harmful and
caused stress to the volunteer (5/12). No difference in
ideal practice was found between medical and non-
medical PIs.
Those who had been PIs for a shorter period of time
were more likely to disclose IFs routinely to the volunteer
than thosewho had been PIs for a longer period (p50.042),
but more experienced investigators were more likely than
less experienced researchers to disclose IFs to the
volunteer if felt to be relevant (p50.020). There were no
other differences in either ideal or current practice by PI
type or research subject characteristics.
Medical PIs were more likely to use a research team
physician than non-medical researchers, as were radio-
logists compared with non-radiologists (both p,0.001).
Figure 1. Research image reporting strategy. Bar charts demonstrating principal investigator (PI) reporting strategies (current
practice unless shown otherwise). The degree of shading reflects how proactive a reporting strategy is (darker indicates more
proactive).
T C Booth, A D Waldman, J M Wardlaw et al
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Table 3. Disclosure of incidental findings to volunteers. This table demonstrates the principal investigator (PI) responses to
questions on disclosure of incidental findings to volunteers: ‘‘when, if at all, does disclosure take place?’’ (3a); ‘‘how does
disclosure take place?’’ (3b); ‘‘who discloses?’’ (3c); and ‘‘if there is no disclosure, why not?’’ (3d)
3a When: frequency of incidental finding disclosure to the volunteer
Number of PIs answering ‘‘yes’’
Current practice n (%) (from a
total of n558)a
Ideal practice n (%) (from a
total of n526)
1. Incidental findings are never disclosed
to the volunteer
11 (19 ) 5 (19)
2. Incidental findings are routinely
disclosed to the volunteer
15 (26) 7 (27)
3. Incidental findings are disclosed to the
volunteer if felt to be of relevanceb
27 (47) 12 (46)
4. Otherc 5 (9) 2 (8)
3b How: method for disclosing an incidental finding to the volunteer
Number of PIs answering ‘‘yes’’
Current practice n (%) (from a
total of n554)a
Ideal practice n (%) (from a total
of n527)
1. Face-to-face 22 (41) 19 (70)
2. By letter 3 (6) 0 (0)
3. By e-mail 0 (0) 0 (0)
4. By telephone 3 (6) 0 (0)
5. Variable and dependent on relevance
of incidental findingd
15 (28) 6 (22)
6. Othere 11 (20) 2 (7)
3c Who: Person disclosing an incidental finding to the volunteer
Number of PIs answering ‘‘yes’’
Current practice n (%) (from
a total of n560)a
Ideal practice n (%) (from a total
of n528)a
1. By volunteer’s own general practitioner 26 (43) 9 (32)
2. By a research clinician who is not a
member of the research team
3 (5) 4 (14)
3. By research team physician 19 (32) 6 (21)
4. By research team non-medical member 0 (0) 0 (0)
5. By research team radiologist 2 (3) 2 (7)
6. Variable and dependent on relevance
of incidental findingf
8 (13) 7 (25)
7. Otherg 2 (3) 0 (0)
3d Why not: reasons for never disclosing incidental findings to research volunteers
Number of PIs answering ‘‘yes’’h
Current practice n (%) (from a
total of n512)
Ideal practice n (%) (from a total
of n512)
1. Logistical – Too much time and
organisation required
1 (8) 1 (8)
2. Financial – No funding to support this 0 (0) 1 (8)
3. Harmful – Stress for research participants 5 (42) 2 (17)
4. Harmful – Medical insurance implications 1 (8) 1 (8)
5. Futile – Incidental findings are
clinically irrelevant
1 (8) 1 (8)
6. Otheri 7 (58) 1 (8)
aTable 3 denominators differ representing the different number of PIs answering individual questions. Some PIs chose two
responses when answering questions that specifically asked for a single response. Rather than exclude this data, these
responses have been weighted as value 0.5 for each response. Summed values to nearest integer.
bHere, PIs gave examples of ‘‘relevance’’. An example of a typical response was: ‘‘something which may have clinical implications
e.g. ovarian cysts or fibroids’’.
cHere, PIs described what they meant by ‘‘other’’. Several explained that rather than deciding themselves whether to disclose an
incidental finding or not, it was the GP or medical practitioner who made that decision.
dPIs described this. Most explained that the method of communication was dependent on the GP‘s clinical judgement.
eHere, PIs described what they meant by ‘‘other’’. All respondents said that the method of communication was dependent on
the GP‘s clinical judgement.
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Non-medical researchers were more likely to use the
volunteer’s own GP in current practice (p,0.001) and also
felt this was ideal practice (p50.033).
Discussion
Summary of findings
This survey captured information from almost half
of all UK PIs, using healthy volunteers in research
imaging, whom we were able to contact through postal
and e-mail approaches. Although nearly 90% of respon-
dents had site-specific guidelines for handling IFs in
healthy volunteers, we found that this guidance, and
the way it is applied, varies widely between sites. Speci-
fically, we demonstrated considerable variation in cur-
rent practice with regard to (a) information given to
volunteers during consent, (b) research scan reporting
strategies and (c) the mechanisms of disclosing IFs.
Differences in consent, reporting and disclosure practice
were associated with investigator background – notably,
whether they were medically trained or radiologists, and
their level of experience. We additionally obtained views
on ideal practice, which we defined as ‘‘practice without
funding or time constraints’’, which also varied among
researchers and almost always differed from current
practice.
Strengths and weaknesses of the study
Inclusion of only PIs of recent imaging studies, the
mixed background characteristics of investigators and
the high response rate suggest that the results represent a
reasonable cross-section of current UK practice. Our
questionnaire was comprehensive and likely to capture
the key details of how IFs are currently handled. None-
theless, this study has limitations. The database used for
recruitment was inevitably incomplete, and respondents
may represent a biased subgroup. Approximately half
the respondents gave no opinion as to what they con-
sidered to be ideal practice, reducing the sample size for
this aspect of the study; the reasons for poor response in
this part of the survey are uncertain. Moreover, although
the questionnaire was designed with care, responses
may reflect varying interpretation of the questions.
Comparison with studies worldwide
There is limited published data on practice in handling
incidental imaging findings in healthy volunteers; all such
data are from outside the UK [9, 15, 16], and the primary
aims of those studies differed from our survey. Wider
interpretation of previous studies is also limited by low
response rate (11%) [16], small sample (12 researchers) [9]
or their scope, such as analysis of information from
research websites only [15]. Some comparisons can, how-
ever, bemadewith these studies performed outside the UK:
N There is wide variability in reporting strategies, with
routine radiologist involvement in less than half of all
practices, in accordance with the findings of Illes et al
(43% in our survey compared with 33% in their
United States-based study) [16].
N We showed that 12.5% of UK PIs do not have
standardised contingency plans for disclosure of IFs.
This is lower than the 47% found among neuroima-
ging investigators in the United States [16] and the
80% in a more general survey of Canadian research
institution activity, which also included handling of
non-imaging research data [17].
N With regard to disclosure, the commonest approach
was to disclose relevant IFs in contrast to Siddiki et al,
who found the most frequent strategy was routine
disclosure (47% in our study compared with Siddiki
et als’ 42% for relevant reporting; 26% in our study
compared with Siddiki et als’ 58% for routine re-
porting) [9]. 19% of PIs in our study never disclosed
IFs, compared with,11% in a United States study that
also incorporated genomic research [15].
N 37% of PIs warned volunteers that re-analysis of the
data in the future may lead to re-contact after the study
has finished. This compares with only 4% in the United
States combined imaging and genomic study [15].
Study explanations and relevance from a national
and international perspective
Consent
Information provided during consent is inadequate in
a notable minority of practice. Although this compares
favourably with available data on United States practice,
the lack of clear contingency arrangements in over 10% of
our sample falls short of mandatory UK NRES require-
ments that all volunteers are adequately informed about
contingency plans, potential benefits and harms should
any IFs be found [18]. Not informing the volunteer about
who is handling their personal data and for what
purposes also contravenes the UK Data Protection Act
[19]. Our finding that radiologists were more likely than
non-radiologists to discuss potential implications of IFs is
likely to reflect greater familiarity with common IFs and
the issues that they raise.
Only about 20% of PIs discussed whether any IFs
are likely to be treatable, which is a European ‘‘Addi-
tional Protocol’’ requirement [20]. This practice was, not
fHere, PIs described what they meant by ‘‘variable’’. Most explained that the person disclosing the incidental finding varies
depending on the circumstance. Therefore, it may be appropriate for a radiologist, physician, GP, treating physician or a nurse
to disclose, depending on the situation.
gHere, it was unknown who would disclose to the volunteer as historically no incidental findings had been discovered.
hRespondents could select more than one item.
iPIs describedwhat theymeant by ‘‘other’’.Most explained that non-clinical staff reviewed scans therefore disclosurewas inappropriate.
Table 3. Continued
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surprisingly, more common among medical PIs than
non-medical researchers.
WHO/UNESCO also recommend discussion prior to
consent of ‘‘the extent of the investigator’s responsibility
to provide medical services to the participant’’ should an
IF be discovered [21]. This ethical guideline is followed
by 42% of PIs in current UK practice; here, medical PIs
were more likely than non-medical PIs to advocate this
as ideal practice.
Just over one-third of PIs warned volunteers that re-
analysis of the data in the future may lead to re-contact
after the study has finished. This compares to only 4% in
the United States [15], although routinely giving such
information is recommended there [2]. The higher per-
centage in the UK may reflect the legal obligation under
the Data Protection Act [19], which underpins the NRES
instruction [18]. Medical PIs were more likely than non-
medical PIs to discuss re-contact, which may again
reflect differences in perception of wider implications
and limits of researchers’ responsibilities.
Reporting
Our findings on radiological reporting suggest wide
variation in practice, which ranged from no radiological
review of images, through reactive policies (where radio-
logical advice was sought only if an abnormality was
noticed by a researcher or radiographer) through to
proactive (all images reviewed by a radiologist) and very
proactive (where additional imaging was performed
routinely to better identify and characterise any inciden-
tal abnormalities) reporting [10]. Medical PIs, especially
radiologists, tended towards more proactive reporting
strategies compared with non-medical investigators.
The only specific UK guidelines on this subject were
Medical Devices Agency recommendations that research
MRIs are routinely reported by a radiologist [22]. These
have recently been superseded by more vague guidelines
from theUKMedicines andHealthcare products Regulatory
Agency (MHRA) [23].
The reasons for investigators not undertaking routine
radiological reporting may reflect lack of access to radio-
logical expertise (particularly for those working in centres
not affiliated to clinical services), cost limitations, limited
awareness of the frequency and implications of IFs, and
opinions as to the extent of responsibility of the study
investigator with regard to detection of such abnormal-
ities [24]. Furthermore, policies of no reporting or reactive
reporting are sometimes justified on the grounds that
detection of IFs lies outside the remit of the research study
[25]. This may, however, be counter to subject’s expecta-
tions [26, 27]. Routine proactive radiological review of
research images is likely to provide more sensitive and
specific detection of significant incidental abnormalities
[24]. The benefit to the subject will clearly be greatest
where detection of pre-symptomatic treatable disease
improves outcome [10]. The images acquired for research
studies are often not optimal for detection of disease
[24], such that a very proactive approach is advocated by
some in the United States on ethical grounds [28] or to
avoid litigation [29]. To optimise scientific integrity of
studies [5] and facilitate appropriate follow-up [30, 31],
these strategies may additionally benefit from specialist
radiologist involvement (e.g. a neuroradiologist reviewing
brain MRI). Our data suggest that proactive policies
have also been adopted in a number of UK centres. The
advantages of proactive reporting must, however, be
balanced against arguments that the purpose of imaging
in such studies is not to screen for unexpected pathology
[25], minimal evidence base demonstrating benefit and
cost implications [10, 24].
Policies for review of research imaging in this con-
text remains a controversial area (Appendix B) [5], with
particular disparities between clinical and non-clinical
imaging groups.
Disclosure
There was variation in practice regarding disclosure of
IFs. In the UK, unless the volunteer requests it [19], there
is no obligation for IFs to be disclosed [10]. The UK
MHRA and WHO/UNESCO recommend that IFs are
routinely disclosed during MRI [23] and all [21] research,
respectively. Although the adverse effects of disclosure
include anxiety, which may be considered unnecessary
if the IF is subsequently shown to be of no clinical
importance [2, 32], available evidence suggests that
volunteers always want to be informed of such findings
[26, 27].
More experienced researchers tended to base decisions
to disclose on whether findings were relevant. Disclosure
of relevant IFs is concordant with the European Addi-
tional Protocol [20]. Only a small percentage of unexpected
findings are clinically relevant [33], and some investigators
consider it unwise to communicate any except those that
are most certain and clinically important [2, 6, 34].
There are a number of possible reasons for the dif-
ferences in disclosure policies between medical and non-
medical researchers. Non-medical investigators are likely
to be less informed about the significance of a finding.
Moreover, non-medical investigators’ experience will be
primarily of a researcher–subject relationship, separate
from wider health concerns, whereas medical investiga-
tors are familiar with an increasingly non-paternalistic
model of the doctor–patient relationship [35], in which
sharing of information with the patient is a central
doctrine.
Only clinical professionals disclosed IFs to volunteers,
consistent with the view that any disclosure to a volunteer
is best done by a medical practitioner experienced in
communicating sensitive medical information [10]. This
goes beyond the European Additional Protocol statement
that relevant IFs should be disclosed within a frame-
work of healthcare or counselling, with an appropriate
clinical professional supervising the research, although
not explicitly disclosing any results themselves [20].
Disclosure was slightly more commonly performed by
GPs (43%) than by research team physicians (32%). This
accorded broadly with ideal practice, but differs from
wishes expressed by United States volunteers in which
there was a strong preference for research team (59%)
compared to the primary care physician (6%) [27]. The
differences may arise in part from the different health-
care models and volunteers’ relationships with primary
care in the United States. The variability in who discloses
IFs in the UK is probably pragmatic, as there is no current
guidance. However, implications can be drawn from the
UK Department of Health guidance that volunteers’ GPs
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should at least be involved [36, 37], thus ensuring effective
communication between members of the patient’s health-
care team and reliable follow-up [38].
Unanswered questions and future directions
The wide variation in the handling of IFs in the UK
is unlikely to be in the best interests of volunteers.
Although many issues around consent and disclosure
are covered by existing domestic legal and international
ethical frameworks, implementation and compliance
vary. In the UK and other nations there are no clear
national guidelines on imaging review and reporting.
Consequently, minimal acceptable standards that accord
with informed consent and volunteers’ expectations and
best interests need to be established. Discrepancies be-
tween UK researchers’ existing and perceived ideal ar-
rangements may reflect resource constraints, and provide
impetus for cost-effective strategies for bridging the gap
between current and best practice. Discussion of UK
research practice for handling IFs is therefore needed, and
will require representation from both clinical and non-
clinical researchers, GPs, and patients’ representatives.
This will allow consensual establishment of practical, law-
ful and ethically defensible UK national guidelines that
can inform NRES advice to ethics committees, and per-
haps set a precedent for other nations.
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Appendix A
Questionnaire: incidental findings discovered in
‘‘healthy’’ volunteers during research imaging
This questionnaire applies to research involving
‘‘healthy’’ volunteers in all organ systems and using all
imaging modalities. This does not apply to ‘‘patient’’
volunteers who are recruited into research projects.
Please apply to the last three years only. Please apply to
your latest imaging research study that has been
approved by an ethics committee.
A. Principal investigator details (please tick all applic-
able boxes in 1a and 1b)
1a Researcher:
% Medical researcher – MBBS or equivalent and
currently practicing medicine
% Non-medical researcher
1b Discipline:
% Basic scientist
% Computer scientist (informatics)
% General physician
% General radiologist
% Geriatrician
% Linguist
% Neurologist
% Neuroradiologist
% Neurosurgeon
% Physicist
% Psychiatrist
% Psychologist
% Stroke physician
% Other (please describe)
2. Years as principal investigator:
3. Size of institution (student number):
% Not applicable
% ,10 000
% 10 000–19 999
% 20 000–29 999
% 30 000–39 999
% .40 000
4. City and county of institution:
5. The research involved (please tick one or more):
% Adults
% Children
6. What organ(s) or system(s) were imaged in the project
in question? (Please tick one or more):
% Bone
% Brain
% Breast
% Cardiac
% Ear, nose throat (please specify below)
% Endocrine (please specify below)
% Eye
% Foetus
% Female reproductive system
% Gastrointestional tract
% Joints
% Liver and biliary tract
% Lymphoreticular system
% Male reproductive system
% Neuromuscular
% Renal
% Respiratory
% Spinal cord
% Urinary tract
% Vascular
% Other (please describe)
7. What research imaging modalities were used in the
project in question? (Please tick one or more)
% fMRI
% MRI diffusion tensor imaging
% MRI perfusion imaging
% MRI diffusion imaging
% MRI permeability imaging
% MRI whole brain volume sequences
%MRI structural sequences (T1, T2, FLAIR, T2*, etc.)
% MRI spectroscopy
% CT perfusion imaging
% CT structural images
% Ultrasound
% SPECT
% PET
% Hybrid (please specify)
% Other (please specify)
The boxes on the left side of the page refer to current
practice. The boxes on the right side of the page refer to ideal
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practice without funding or time constraints. Please tick boxes
on both the left and right as appropriate.
B. Informed consent.
During the process of obtaining informed consent of
the volunteer by the researcher, information is provided
on the following (please tick all applicable boxes)
% What happens to the patient’s personal data %
% Contingency plans should any incidental findings
be found [examples are: (1) a suitable mechanism is
always in place for disclosure of an incidental
finding to the volunteer; (2) the plan is to always
not disclose] %
% Disclosure of any incidental findings to the
volunteer themselves by a member of the research
team %
% Disclosure of any incidental findings to the
volunteer’s general practitioner/treating clinician%
% Whether any incidental findings are likely to be
treatable %
% Potential benefits of any incidental findings should
they be found (e.g. prophylactic intervention) %
% Potential harms of any incidental findings should
they be found (e.g. medical insurance being
affected) %
% The extent (if any) of the investigator’s responsi-
bility to provide medical services should any
incidental finding be found %
% Potential future re-contact in anticipation that the
data be re-analysed in the future after this project
has finished %
C. Disclosure.
Which one of the following items best describes
arrangements for disclosure to the volunteer if an
incidental finding is discovered? (Tick once in each
column)
1. % Incidental findings are never disclosed to the
volunteer (if this is the best response please
answer all questions except F and G) %
2. % Incidental findings are routinely disclosed to the
volunteer %
3. % Incidental findings are disclosed to the volunteer if
felt to be of relevance (please give example of what
you consider to be of relevance) %
4. % Other (please describe) %
D. Non-disclosure.
Only answer this question if you chose response 1 in
question C. Which of the following item(s) describes why
incidental findings are never disclosed to research
volunteers? (Please select one or more item)
% Logistical – too much time and organisation
required %
% Financial – no funding to support this %
% Harmful – stress for research participant %
% Harmful – medical insurance implications %
% Futile – incidental findings are clinically irrelevant%
% Other (please describe)
E. Standardised contingency plan.
Is there a standardised contingency plan for incidental
findings? [Examples are: (1) a suitable mechanism is
always in place for disclosure of an incidental finding to
the volunteer; (2) the plan is always not to disclose]
% Yes %
% No %
If yes, please describe briefly:
F. Disclosure method.
Which of the following stems best describes how
incidental findings are disclosed to the volunteer
[please tick a single box in each column in F(a) and
F(b)]
F(a) By whom:
% By volunteer’s own general practitioner %
% By a clinician who is not member of research team%
% By research team physician %
% By research team non-medical member %
% By research team radiologist %
% Variable and dependent on relevance of incidental
finding (please describe) %
% Other (please describe) %
F(b) Means of communication:
% Face to face %
% By letter %
% By e-mail %
% By telephone %
% Variable and dependent on relevance of inci
dental finding (please describe) %
% Other (please describe) %
G. Radiology reporting.
Which one of the following stems best describes how
radiologists report research scans?
% Radiologists do not report research scans %
% Radiologists report research scans only if a
researcher is suspicious of an incidental finding%
% Radiologists report research scans in their spe-
cialist field (e.g. neuroradiologists reporting
brains) only if a researcher is suspicious of an
incidental finding %
% Radiologists report all research scans routinely%
% Radiologists report all research scans routinely in
their specialist field (e.g. neuroradiologists report-
ing brains) %
% Research scans and also clinical scans addi-
tional to those necessary for the project are
routinely obtained and all are reported by a
radiologist %
% Research scans and also clinical scans additional
to those necessary for the project are routinely
obtained and all are reported by a radiologist in
their specialist field (e.g. neuroradiologists report-
ing brains) %
% Other (please describe) %
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Appendix B
A selection of comments invited following survey
completion.
N I do not believe that it is cost effective or practical to
require additional ‘‘clinical’’ scans and radiological
reading on all studies. I believe our current practice of
following up only on suspicious findings, and clearly
badging the imaging we do as ‘‘research that may
have no diagnostic value’’, is the right one.
N If scans are routinely reported it would add signifi-
cantly to the costs of research, for no obvious gain.
N The reporting is time-consuming and not trivial, but
having run a research scanner for twelve years and
research imaging on (UK) National Health Service
scanners before that, we have decided that there isn’t
any other ethical way of doing it. It’s not fair on the
volunteer not to look after their scan findings.
N Long overdue. We must implement a standardised
best practice across all institutions which have
imaging equipment capable of detecting pathology.
Too many ‘‘toys’’ are being installed in basic science/
physics/psychology departments without a clear
understanding of the ethical implications.
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